Alzheimer's Fast Track 2025
Join us for Alzheimer’s Fast Track, November 12-14, 2025, in San Diego, CA.
About Alzheimer’s Fast Track
Learn from experts in the field of Alzheimer’s disease and related dementias at the Alzheimer’s Fast Track workshop. Designed for graduate students, postdoctoral fellows, and other early-career scientists focused on Alzheimer’s disease research, this immersive learning experience will accelerate your knowledge, expertise, and visibility in this exciting field.
2025 Event Details
November 12-14, 2025
The Bahia Resort Hotel
San Diego, CA
Official pre-meeting to Society for Neuroscience
Contact researchgrants@brightfocus.org with questions.
What Attendees Are Saying
I cannot believe how much this BrightFocus Fast Track has shaped my knowledge, my career and me personally. I also made friends forever. Not only I am so much more prepared and more confident to write grants but also I gained skills to communicate and to share my science. This workshop is the greatest idea to help students build their careers more successfully. Every scientist should go through a workshop like this one. Thank you for the opportunity!
Amira Latif-Hernandez, PhD, Alzheimer’s Disease Research Grant Recipient and Fast Track Attendee
The BrightFocus team shows genuine care for their fellows and their individual career paths, which was evident during the Fast Track event. The opportunity to easily connect with mentors and receive personalized advice truly stood out.
Julie Ottoy, PhD, Alzheimer’s Disease Research Grant Recipient and Fast Track Attendee
Co-Chairs
Frank LaFerla, PhD
University of California, Irvine
Cynthia Lemere, PhD
Brigham and Women’s Hospital, Harvard Medical School
Sharyn Rossi, PhD
BrightFocus Foundation
Harry Steinbusch, PhD
Maastricht University,
The Netherlands
Related News & Research Breakthroughs
Article
New Blood Test Could Personalize Alzheimer’s Treatment Like Never Before
A new Alzheimer’s blood test may reveal how far the disease has progressed and identify who’s most likely to benefit from anti-amyloid therapies.
Article
What Early-Life Brain Activity May Reveal About Alzheimer’s Risk
BrightFocus Alzheimer’s Disease Research grant recipient Keith Hengen, PhD, is pioneering a novel approach to identifying Alzheimer’s risk in early life, which could enable earlier diagnosis, risk reduction, and treatment.
Article
FDA Clears First Blood Test to Aid in Alzheimer’s Diagnosis
The Lumipulse G β-Amyloid Ratio (1-42/1-40) blood test, manufactured by Fujirebio Diagnostics, measures two forms of amyloid-beta in the blood.
Article
Does Disrupting the Brain’s Clock Influence Alzheimer’s?
An Alzheimer’s Disease Research-funded researcher is investigating the link between circadian rhythm disruption by jet lag and Alzheimer’s in the hopes of finding new treatment targets.
Article
Breaking News Dispatch: Alzheimer’s Drug Breakthroughs and Care Access Tools
Read the top headlines in Alzheimer’s clinical trials and healthcare platforms.
Article
A BrightFocus-Funded Non-Invasive Treatment Slows Alzheimer’s Progression in Yearlong Study
Sinaptica Therapeutics unveils breakthrough Phase 2 results for an experimental non-invasive treatment for Alzheimer’s disease.